-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse DüsseldorfSymbol 38I-
Intellia TherapeuticsBörse Börse FrankfurtSymbol 38I
-
Intellia TherapeuticsBörse Börse MünchenSymbol 38I
-
INTELLIA THERAPEUTICS INCBörse Börse StuttgartSymbol 38I
-
INTELLIA THERAPEUTICS INCBörse Gettex System der Börse MünchenSymbol 38I
-
INTELLIA THERAPEUTICS INCBörse Quotrix System der Börse DüsseldorfSymbol 38I
-
INTELLIA THERAPEUTICS INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol 38I
-
INTELLIA THERAPEUTICS INCBörse Börse DüsseldorfSymbol 38I
-
ISIN US45826J1051 WKN: A2AG6HSymbol NTLA
-
Symbol 38I
-
Intellia Therapeutics, Inc.Börse London Stock Exchange
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
4.410.512.384 oder 8.662.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
270 oder 598 Mitarbeiter
Entdecke die 6 ETFs in denen Intellia Therapeutics, Inc am höchsten gewichtet ist Insgesamt in 10 ETFs enthalten
Dir gefallen die Informationen zu Intellia Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Intellia Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Intellia Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Intellia Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
117 News & Informationen zur Intellia Therapeutics Aktie
Global CRISPR Markets to 2026: Focus on Design Tools, Plasmid and Vector, Cas9 and g-RNA, Delivery System Products
/PRNewswire/ — The
Global CRISPR Markets To 2026: Focus On Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products
DUBLIN, Sept. 21, 2021 /PRNewswire/ — The
Is Intellia Therapeutics (NTLA) A Great Investment Pick?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Intellia Therapeutics Inc (NTLA) EVP, CFO Glenn Goddard Sold $627,178 of Shares
GuruFocus Article or News written by insider and the topic is about:
10 Top Stem Cell Companies on the NASDAQ
Stem cell research and regenerative medicines are growing life science market segments. Here are the 10 top stem cell companies on the NASDAQ
Hemophilia B (Factor IX Deficiency) Drugs In Development, 2021
/PRNewswire/ — The
Intellia Therapeutics Inc (NTLA) EVP, CFO Glenn Goddard Sold $4.8 million of Shares
GuruFocus Article or News written by insider and the topic is about:
ETFs That Short The Market (Inverse ETFs)
Investors looking to hedge against investment risk should consider ETFs that short the market. Find out more about inverse ETFs.
12 Best ARK Stocks To Invest In
As technology and growth stocks surged during the pandemic, ARK Investment Management and Cathie Wood became two of retail investors' favorites over the previous year.
Intellia Therapeutics Inc (NTLA) President and CEO John M Leonard Sold $4.1 million of Shares
GuruFocus Article or News written by insider and the topic is about:
PDT Partners, LLC Buys Stellantis NV, Asana Inc, Charles River Laboratories International Inc, Sells Ferrari NV, Tesla Inc, The Toro Co
GuruFocus Article or News written by insider and the topic is about:
SG3 Management, LLC Buys Alphabet Inc, Moderna Inc, Amgen Inc, Sells Alphabet Inc, Biogen Inc, Aon PLC
GuruFocus Article or News written by insider and the topic is about:
Intellia Therapeutics Inc (NTLA) President and CEO John M Leonard Sold $3.4 million of Shares
GuruFocus Article or News written by insider and the topic is about:
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest Buys for August 19, 2021.
Cathie Wood’s ARK Invest Buys Over 1.3 Million Shares of This Health Information Company – 24
One of Cathie Wood's ARK Invest funds bought over 1.3 shares of Sema4 on August 17.
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest Buys for August 17, 2021.
Cathie Wood’s ARK Invest Buys Over 2.5 Million Shares of Palantir – 24
A few of Cathie Wood's ARK Invest funds bought over 2.5 million shares altogether of Palantir on August 16.
Will Moderna’s Interest Boost Gene Editing Stocks?
Our indicative theme of Gene Editing stocks has returned about 11% year-to-date, compared to the S&P 500 which is up by about 19% over the same period. However, the gains have overwhelmingly come from a single stock, Intellia Therapeutics, which is up by about 3x year-to-date, after the company…
Discovery Value Fund Buys Roblox Corp, Intellia Therapeutics Inc, Coinbase Global Inc, Sells Coupa Software Inc, Peloton Interactive Inc, Li Auto Inc
GuruFocus Article or News written by insider and the topic is about:
Cathie Wood’s ARK Invest Buys Over 800,000 Shares of Signify Health – 24
One of Cathie Wood's ARK Invest funds bought over 800,000 shares of Signify Health on August 11.
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest Buys for August 11, 2021.
Intellia Therapeutics Inc (NTLA) EVP, CFO Glenn Goddard Sold $3 million of Shares
GuruFocus Article or News written by insider and the topic is about:
Intellia Therapeutics Inc. Stock Quote (U.S.: Nasdaq)
NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Why Shares of Intellia Therapeutics Are Jumping Today
More progress in the pipeline has investors bullish on the company's shares.
Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q2 2021 Results – Earnings Call Transcript
Call Start: 08:00 Call End: 09:00 Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -65.57% and -45.54%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Established proof of concept for the Company’s modular in vivo delivery platform with first-ever clinical data from systemically administered CRISPR genome…
Cell and Gene Therapy Firms Grab Over $11 Billion So Far in 2021
Arlington, VA (PRWEB) August 05, 2021 — There has been at least $11.2 billion in announced financing for cell and gene therapy-related companies in 2021,
5 Most Profitable Holdings of Catherine Wood's ARK
GuruFocus Article or News written by Graham Griffin and the topic is about: Unique investments racking up large profits
Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Intellia Therapeutics, Inc. (NTLA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intellia Therapeutics To Hold Conference Call To Discuss Second Quarter 2021 Earnings And Company Updates
CAMBRIDGE, Mass., July 29, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on
3 Things About Regeneron That Smart Investors Know
The biotech's COVID-19 antibody cocktail made headlines last year, but there's a bigger story here.
Were Hedge Funds Right About Dumping Crane Co. (CR)?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
Intellia Therapeutics, Inc. (NTLA) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Intellia Therapeutics, Inc. (NTLA) closed at $132.37, marking a -1.22% move from the previous day.
3 Reasons Caribou Biosciences Could Be the Best Gene-Editing Stock for Your Portfolio
The company has a pedigree and a novel approach that could put it at the top of the CRISPR heap.
DGAP-News: Il settore delle biotecnologie archivia un secondo trimestre all'insegna della solidit? BB Biotech aumenta gli investimenti in small e mid cap promettenti
DGAP-News: BB BIOTECH AG / /Rapporto intermedio
Il settore delle biotecnologie archivia un secondo trimestre all'insegna della solidità – BB Biotech aumenta gli
investimenti in small e mid cap… | July 23, 2021
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.